Morten Sommer

[Morten Sommer @moasommer]

Excited to share the research that lead to @sniprbiome development candidate for selective targeting of E. coli in the gut using #CRISPR armed #phages https://t.co/ikFAl7tO5V

[Morten Sommer @moasommer]

Microbes are already used for food production, yet, their potential for making new healthy and sustainable foods is far from exhausted. Learn more about the Microbial Foods field here: https://t.co/7pO8MDS6jF @CellCellPress @DTUBiosustain @novonordiskfond

[Morten Sommer @moasommer]

Characterization of new #biosensors for E coli #Nissle to aid the design of Advanced #microbiome Therapeutics https://t.co/gNA1GUwI4E

[Franck Touret @Franck_who]

Happy to share our collaborative work on the in vitro evaluation of Niclosamide in primary bronchial cells.
#PLOSONE: Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a c ... https://t.co/Or1pRzKcKP

[Morten Sommer @moasommer]

@DrJDennehy @mbiojournal @fabspagnolo Great review of our knowledge of the pre-antibiotic era environmental origins of antibiotic resistance.

[Harris Wang @harriswangnyc]

I’m really honored to be one of the recipients of this year’s Vilcek Prizes for Creative Promise. America is truly a land of opportunities. My parents immigrated to the US w/ nothing but dreams & hopes when I was young. I’m glad to be able to build a life and career here in 🇺🇸

[Eric Topol @EricTopol]

An update on Delta, vaccination protection and viral loads from the aggregate data available, with new @PHE_uk data
1. Delta infections are characterized by very high viral loads (low Cts). When a breakthrough occurs, the load is similar to unvaccinated, but clears more rapidly

[Morten Sommer @moasommer]

#Niclosamide has activity against Variants of Concern of #SARS_CoV_2, including B.1.1.7 and B.1.351.
https://t.co/o2Sw8nl97G
@UNION_Tx @DTUBiosustain @DTUtweet

[Morten Sommer @moasommer]

Our new paper describes a computational framework for assessing future dissemination of antibiotic resistance genes based on the gene exchange networks of their mobile elements. @DTUBiosustain @DTUtweet @novonordiskfond @lundbeckfonden @NatureComms

https://t.co/76zXL3VM7O

[Pooja Jha @PoojaJha2015]

Data from this study support testing of UNI91104, a promising candidate for viral respiratory infections such as COVID19, in patient trials.

Transient irritation in the upper respiratory tract was the most frequent adverse event. Nasal application did not result in any AE.

[Morten Sommer @moasommer]

Excited to share Phase 1 results from @UNION_Tx inhaled & intranasal niclosamide formulation. The good HV tolerability and broad antiviral effect opens exciting perspectives for the treatment of respiratory infections - including #COVID19
https://t.co/wdlncOUY60
@DTUtweet

[Morten Sommer @moasommer]

@UNION_Tx Excited to see Urgent Public Health Prioritization for the PROTECT-V trial that investigates UNI91103 for pre-exposure prophylaxis in patients particularly vulnerable to COVID-19.

[Aoifemlbrennan @aoifemlbrennan]

Yesterday we announced positive data from the first part of our phase 1 trial of SYNB8802. We are developing SYNB8802 as a potential treatment for patients who have high oxalate absorption from the GI tract which causes progressive kidney damage. How did we get here? 🧵 1/9

[King Lab @KingLabIPD]

Happy to announce that our work on broadly protective nanoparticle-based influenza vaccines has been published in Nature! https://t.co/iwWQonNElz

Supraseasonal flu vaccine = protects against seasonal flu even when that year's strain prediction is off, plus some more
1/9

[NEJM @NEJM]

The emergence of the #SARSCoV2 variants B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351) and P.1 (B.1.1.28.1) has aroused many concerns, including worsening #COVID19 and escape from vaccine-induced immunity.

[World Economic Forum @wef]

Alternative proteins will transform food, mitigate climate change and drive profits. Here's how. @BCG https://t.co/CrtCFbifOg

[Eric Topol @EricTopol]

Just out @TheLancet: Largest study of reinfection, whole country of Denmark
—0.65% after prior covid
—Protection ~80%, lasts ≥ 7 months
—Age ≥ 65 protection reduced to 47%
https://t.co/xMn3tKaja0
@SteenEtTo @uni_copenhagen @SSI_dk

[Carlsbergfondet @Carlsbergfondet]

🎧Podcast: Intelligente tarmbakterier behandler hjernesygdomme 🦠Mikrobiolog @moasommer fortæller om arbejdet med at udvikle skræddersyede mikrober som ‘levende medicin’ 👉https://t.co/2uqNfUjZEe #dkforsk #sundpol

[Morten Sommer @moasommer]

Using synthetic microbial communities mimicking the Brazilian sugarcane ethanol fermentation we reveal L. amylovorus as an industrial probiotic that may improve process yield. Our collaboration with @asanchez_lab is published in @NatureComms https://t.co/4XTcQ6byBo. @DTUtweet

[Morten Sommer @moasommer]

Great blog post on the need for inhaled #antivirals for treatment of #COVID-19 in the community setting.

https://t.co/MQo7qejdeI